Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Hernàndez S, Morén C, López M, Coll O, Cardellach F, Gratacós E, Miró O, Garrabou G.

AIDS. 2012 Feb 20;26(4):419-28. doi: 10.1097/QAD.0b013e32834f3232.

PMID:
22156962
2.
3.

[Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].

Boer K, Nellen JF, Kreyenbroek ME, Godfried MH.

Ned Tijdschr Geneeskd. 2009;153:B410. Review. Dutch.

PMID:
19785876
4.
5.

The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?

Martin F, Taylor GP.

J Antimicrob Chemother. 2009 Nov;64(5):895-900. doi: 10.1093/jac/dkp303. Epub 2009 Aug 25. Review.

PMID:
19706669
6.

Cardiovascular effects of HAART in infants and children of HIV-infected mothers.

Zareba KM, Lavigne JE, Lipshultz SE.

Cardiovasc Toxicol. 2004;4(3):271-9. Review.

PMID:
15470274
7.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
8.

[Human immunodeficiency virus (HIV) infection in pregnancy: antiretroviral treatment (ART) and mode of delivery].

Abarzúa F, Nuñez F, Hubinont C, Bernard P, Yombi JC, Vandercam B.

Rev Chilena Infectol. 2005 Dec;22(4):327-37. Epub 2005 Dec 5. Review. Spanish.

9.

Pharmacotherapy of perinatal HIV.

Capparelli E, Rakhmanina N, Mirochnick M.

Semin Fetal Neonatal Med. 2005 Apr;10(2):161-75. Epub 2005 Jan 20. Review.

PMID:
15701581
10.

Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.

Poirier MC, Gibbons AT, Rugeles MT, Andre-Schmutz I, Blanche S.

Curr Opin Pediatr. 2015 Apr;27(2):233-9. doi: 10.1097/MOP.0000000000000193. Review.

11.

The impact of highly active antiretroviral therapy on obstetric conditions: A review.

Sebitloane HM, Moodley D.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:126-131. doi: 10.1016/j.ejogrb.2016.12.008. Epub 2016 Dec 9. Review.

PMID:
28013100
12.

Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Buckoreelall K, Cressey TR, King JR.

Clin Pharmacokinet. 2012 Oct 1;51(10):639-59. Review.

PMID:
23018528
13.

Antiretroviral therapy and preterm birth in HIV-infected women.

Short CE, Taylor GP.

Expert Rev Anti Infect Ther. 2014 Mar;12(3):293-306. doi: 10.1586/14787210.2014.885837. Epub 2014 Feb 6. Review.

PMID:
24502750
14.

The safety of antiretroviral drugs in pregnancy.

Thorne C, Newell ML.

Expert Opin Drug Saf. 2005 Mar;4(2):323-35. Review.

PMID:
15794723
15.

Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Altfeld M, Bunders MJ.

Semin Immunopathol. 2016 Nov;38(6):727-738. Epub 2016 Jul 8. Review. Erratum in: Semin Immunopathol. 2016 Nov;38(6):783-784.

PMID:
27392971
16.

Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.

Uthman OA, Nachega JB, Anderson J, Kanters S, Mills EJ, Renaud F, Essajee S, Doherty MC, Mofenson LM.

Lancet HIV. 2017 Jan;4(1):e21-e30. doi: 10.1016/S2352-3018(16)30195-3. Epub 2016 Nov 16. Review.

17.

Perinatal tuberculosis and HIV-1: considerations for resource-limited settings.

Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H.

Lancet Infect Dis. 2004 Mar;4(3):155-65. Review.

PMID:
14998501
18.

HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.

Lipshultz SE, Mas CM, Henkel JM, Franco VI, Fisher SD, Miller TL.

Expert Rev Anti Infect Ther. 2012 Jun;10(6):661-74. doi: 10.1586/eri.12.53. Review.

PMID:
22734956
19.

[Antiretroviral agents and pregnancy: mitochondrial dysfunction and nucleoside analogs].

Loubeyre-Unique C, Gautier A, Vauzelle-Gardier C, Champart AM, Bavoux F.

Therapie. 2001 May-Jun;56(3):261-6. Review. French.

PMID:
11475805
20.

Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Jao J, Abrams EJ.

Pediatr Infect Dis J. 2014 Jul;33(7):734-40. doi: 10.1097/INF.0000000000000224. Review.

Supplemental Content

Support Center